Scarica l'app Stockscreener
1.5599
5.51%
-0.0901
Telomir Pharmaceuticals Inc Borsa (TELO) Ultime notizie
Tools to assess Telomir Pharmaceuticals Inc.’s risk profileWeekly Risk Report & AI Forecasted Entry and Exit Points - newser.com
What to do if you’re stuck in Telomir Pharmaceuticals Inc.July 2025 Highlights & Weekly Breakout Opportunity Watchlist - newser.com
Why Telomir Pharmaceuticals Inc. is moving todayMarket Rally & Free Community Supported Trade Ideas - newser.com
Telomir Pharmaceuticals Inc Stock Analysis and ForecastLong-Term Investment Plans & Download Our Free Trading Blueprint - earlytimes.in
What drives Telomir Pharmaceuticals Inc stock priceIndustrial Stocks Review & Free Transform Portfolio With Stocks - earlytimes.in
Telomir Pharmaceuticals Announces New Findings in a Prostate Cancer Model Demonstrating Telomir-1 Also Resets DNA Methylation of Tumor Suppressor Genes Implicated in Two of the Most Persistent Challenges in Oncology-Metastasis and Treatment Re - Shreveport Times
Why Telomir Pharmaceuticals Stock Is Rising 40% Premarket Today - Stocktwits
Telomir Pharmaceuticals Reports Discovery That Telomir-1 Selectively Kills Aggressive Triple-Negative Breast Cancer Cells - DelmarvaNow.com
Institutional scanner results for Telomir Pharmaceuticals Inc.2025 Fundamental Recap & Risk Controlled Stock Alerts - newser.com
How to monitor Telomir Pharmaceuticals Inc. with trend dashboardsJuly 2025 Trade Ideas & Daily Chart Pattern Signal Reports - newser.com
Telomir Pharmaceuticals Inc. (TELO) Stock Price | Live Quotes & Charts | NSC - StocksToTrade
Why Is Telomir Pharmaceuticals Stock Trading Higher Today?Telomir Pharmaceuticals (NASDAQ:TELO) - Benzinga
Telomir Pharmaceuticals Announces In Vitro Data Showing Telomir-1 Targets Additional Histone Demethylase Families, a Unique Profile in Cancer and Aging Not Seen in Other Therapies - The Florida Times-Union
Telomir stock soars after drug shows promise against aggressive breast cancer - Investing.com
Telomir Pharma’s Cutting-Edge Cancer Breakthrough - StocksToTrade
Telomir’s Investigational Therapy: A Game Changer? - timothysykes.com
Pre-Market Titans: TTRX, BJDX & UPC Set The Pace - RTTNews
Telomir-1 shows promise against triple-negative breast cancer By Investing.com - Investing.com South Africa
Selective killing of aggressive TNBC cells: Telomir's Telomir‑1 disrupts iron-driven energy and mitochondrial function - Stock Titan
Why Richardson Electronics Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket - inkl
Weiss Ratings Reiterates “Sell (E+)” Rating for Telomir Pharmaceuticals (NASDAQ:TELO) - Defense World
Telomir Pharmaceuticals Telomir-1 selectively kills aggressive triple-negative breast cancer cells - MarketScreener
Telomir Pharmaceuticals Unveils Promising Cancer Treatment Discovery - TipRanks
Telomir shares surge after breakthrough tumor suppressor gene reactivation data - MSN
Telomir stock soars after tumor suppressor gene reactivation results - Investing.com
Stock Market Today: Dow Jones, Nasdaq 100, S&P 500 Futures Turn Green—Trilogy Metals, AMD, Applovin In Focus (UPDATED) - Benzinga
Morning Market Movers: SPRB, LXEO, BMEA, Seeing Big Swings - RTTNews
Telomir Says Investigational Therapy Reactivates Tumor Suppressor Genes in Preclinical Models - MarketScreener
Telomir-1 shows promise in reactivating tumor suppressor genes By Investing.com - Investing.com Nigeria
Telomir-1 shows promise in reactivating tumor suppressor genes - Investing.com
Telomir Telomir-1 Resets DNA Methylation of MASPIN, RASSF1A | TELO Stock News - Stock Titan
Why Telomir Pharmaceuticals Shares Are Trading Higher By 31%; Here Are 20 Stocks Moving Premarket - Benzinga
Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) Sees Significant Decrease in Short Interest - Defense World
McCormick, Telomir Pharmaceuticals And 3 Stocks To Watch Heading Into Tuesday - Benzinga
0.12%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):